Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008994 · ClinicalTrials.gov registry record · Phase 2
Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
A Phase 2 study, sponsored by Sanford Health.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT02008994 is a Phase 2 study that was terminated before completion, run by Sanford Health. The registered enrollment target is 5 participants.
The verdict
NCT02008994, a Phase 2 study, was terminated before completion, sponsored by Sanford Health.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
Genes are the basic "instruction book" for the cells that make up our bodies and are made out of DNA. Many research studies are done to find the best possible way to treat patients with cancer. Recently there has been a great deal of interest in developing new anticancer agents that are more targeted to a patient's individual genetic information, as well as diseases caused by defects in a person's genes. Identification of precisely which treatments to use against a specific patient's tumor is challenging. In this study, four cutting-edge technologies will be used to identify genomic (information we get from DNA and RNA) and proteomic (information we get from proteins) targets for the treatment of your tumor. These four tests will be used together to gather information about your tumor giving doctors and scientists a better understanding of the structure of your tumor and what the best treatment or combination of treatments may be for you. The therapy you receive to treat your tumor will be based on your medical history, previous treatments for your disease if applicable, current state of health, and the findings from these four tests. The therapy you ultimately receive will be selected by your doctor in consultation with a panel of experts in cancer and cancer genomics (the Treatment Selection Committee).
Interventions
- OTHER Genomic and Proteomic Profiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02008994
The ClinicalTrials.gov registry entry for NCT02008994 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genomic and Proteomic Profiling is the first listed.
NCT02008994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02008994 about?
NCT02008994 is a clinical study titled "Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer". Genes are the basic "instruction book" for the cells that make up our bodies and are made out of DNA. Many research studies are done to find the best possible way to treat patients with cancer. Recently there has been a great deal of interest in developing new anticancer agents that are more targete...
What is the current status of trial NCT02008994?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2013-09. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02008994?
The interventions under investigation include: Genomic and Proteomic Profiling (OTHER).
Who is sponsoring clinical trial NCT02008994?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.